Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morrison, C. Pfizer's CDK4/6 inhibitor approved for advanced breast cancer. Nat Biotechnol 33, 323–324 (2015). https://doi.org/10.1038/nbt0415-323
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0415-323
- Springer Nature America, Inc.
This article is cited by
-
Astex shapes CDK4/6 inhibitor for approval
Nature Biotechnology (2017)